SurGenTec’s OsteoFlo HydroFiber FDA cleared for standalone use
By Admin | January 16, 2026
OsteoFlo HydroFiber uses web interface technology to prevent graft migration and ensure cohesiveness and flowability, according to a news release. It is designed for use in interbody fusion cages, disc spaces, and posterolateral fusions. The product can also be used with SurGenTec’s Graftgun for backfilling interbody cages.
“OsteoFlo HydroFiber provides a novel, customizable solution for surgeons, tailored to both anatomy and procedure type,” CEO and founder of SurGenTec, Travis Greenhalgh, said in the release. “Physicians are familiar with the handling characteristics of...(More)
For more please read, SurGenTec’s OsteoFlo HydroFiber FDA cleared for standalone use, by Becker's Spine Review
